본문으로 바로가기

의료진 소개

이동현 의사

이동현 교수


이대비뇨기병원장 비뇨의학과, 방광암/인공방광센터 관심의료진 등록

전문 진료 분야

방광암, 인공방광 수술, 혈뇨

진료 일정

학력 및 경력사항

학력사항

  • 연세대학교 대학원 (의학박사)
  • 연세대학교 대학원 (의학석사)
  • 연세대학교 의과대학 졸업

교육 및 연구경력

  • 2022-현재  | 이대비뇨기병원장
  • 2016-현재  | 이대목동병원 방광암/인공방광센터장
  • 2015-2017  | 이화의료원 진료부원장
  • 2007-2008  | 미국 뉴저지의대연수, 복강경수술 및 로봇수술 연수
  • 2003  | 미국 남가주 Irvine 의대 연수, 내시경수술 및 로봇수술 연수
  • 2001-현재  | 이화여자대학교 비뇨기과 교수
  • 2001-현재  | 의학전문대학원 비뇨기과 주임교수 겸 과장
  • 2000-2001  | 일산병원 비뇨기과 과장
  • 1997-1998  | 미국 Baylor College 의대 연수, 방광암 및 신장암, 전립선암 연구
  • 1997  | 미국 Mayo Clinic 연수, 전립선암 연구
  • 1996-2000  | 연세의대 비뇨기과학교실 연구강사

논문

  •  Expression and Prognostic Implication of PD-L1 in Patients with Urothelial Carcinoma with Variant Histology (Squamous Differentiation or Micropapillary) Undergoing Radical Cystectomy.  Biomedicines. 2022, v.10 no.4, 910. 
  •  Diagnostic value of urine cytology in detecting histologic variants of urothelial carcinomas in the urinary bladder: Cytopathologic correlation of 72 cases.  DIAGNOSTIC CYTOPATHOLOGY. 2021, v.49 no.3, 367-373. 
  •  Feasibility and Safety of Stentless Uretero-Intestinal Anastomosis in Radical Cystectomy with Ileal Orthotopic Neobladder.  JOURNAL OF CLINICAL MEDICINE. 2021, v.10 no.22, 5372. 
  •  Prognostic Role of Programmed Death Ligand-1 on Tumor-Infiltrating Immune Cells in "High-Risk" Patients Following Radical Cystectomy: A Retrospective Cohort Study.  FRONTIERS IN ONCOLOGY. 2021, v.11, 0. 
  •  Prognostic Value of Programmed Death Ligand-1 Expression on Tumor-Infiltrating Immune Cells in Patients Treated with Cisplatin-Based Combination Adjuvant Chemotherapy Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Cohort Study.  ONCOTARGETS AND THERAPY. 2021, v.14, 845-855. 
  •  Ambulatory second look percutaneous nephrolithotripsy with maturated nephrostomy tract.  International Braz J Urol. 2020, v.46 no.4, 676-676. 
  •  Comparison of Four Commercial Kits for Isolation of Urinary Cell-Free DNA and Sample Storage Conditions.  DIAGNOSTICS. 2020, v.10 no.4, 234. 
  •  Programmed Cell Death-Ligand 1 Expression Status in Urothelial Carcinoma According to Clinical and Pathological Factors: A Multi-Institutional Retrospective Study.  Frontiers in Oncology. 2020, v.10, 568809. 
  •  Risk Factors for Urethral Recurrence in Men After Radical Cystectomy with Orthotopic Urinary Diversion for Urothelial Carcinoma: A Retrospective Cohort Study.  CANCER MANAGEMENT AND RESEARCH. 2020, v.12, 6739-6746. 
  •  Single-port robot-assisted radical prostatectomy with the da vinci sp system: A single surgeon’s experience.  Investigative and Clinical Urology. 2020, v.61 no.2, 173-179. 
  •  Surgical Outcomes of Transvaginal Neobladder-Vaginal Fistula Repair After Radical Cystectomy with Ileal Orthotopic Neobladder: A Case-Control Study.  CANCER MANAGEMENT AND RESEARCH. 2020, v.12, 10279-10286. 
  •  진행성 전립선암의 치료: 국내 전립선암 전문가로 구성된 Prostate Cancer Summit (PCAS) 2016을 통한 전립선암 치료 지침의 확인.  대한비뇨기종양학술지. 2020, v.18 no.2, 124-139. 
  •  Efficacy and Safety of On Demand Clomipramine for the Treatment of Premature Ejaculation: A Multicenter, Randomized, Double-Blind, Phase III Clinical Trial.  The Journal of urology. 2019, v.201 no.1, 147-152. 
  •  Impact of a change in duration of prophylactic antibiotics on infectious complications after radical cystectomy with a neobladder.  MEDICINE. 2018, v.97 no.47, e13196. 
  •  Role of bowel suspension technique to prevent early intestinal obstruction after radical cystectomy with ileal orthotopic neobladder: A retrospective cohort study.  INTERNATIONAL JOURNAL OF SURGERY. 2018, v.55, 9-14. 
  •  Tolerability and adequate therapeutic dosage of oral clomipramine for the treatment of premature ejaculation: A randomized, double-blind, placebo-controlled, fixed-dose, parallel-grouped clinical study.  INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH. 2018, v.30 no.2, 65-70. 
  •  Urinary Exosomal and cell-free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of Bladder.  Scientific Reports. 2018, v.8 no.1, 14707. 
  •  Cluster analysis identifies three urodynamic patterns in patients with orthotopic neobladder reconstruction.  PLoS ONE. 2017, v.12 no.10. 
  •  Enhanced Application of 18F-FDG PET/CT in Bladder Cancer by Adding Early Dynamic Acquisition to a Standard Delayed PET Protocol.  Clinical Nuclear Medicine. 2017, v.42 no.10, 749-755. 
  •  Impact of Gleason score on biochemical recurrence in patients with pT3aN0/Nx prostate cancer with positive surgical margins: a multicenter study from the Prostate Cancer Research Committee.  Journal of Cancer Research and Clinical Oncology. 2017, v.143 no.11, 2393-2400. 
  •  Febrile Urinary Tract Infection after Radical Cystectomy and Ileal Neobladder in Patients with Bladder Cancer.  JOURNAL OF KOREAN MEDICAL SCIENCE. 2016, v.31 no.7, 1100-1104. 
  •  Risk factors for developing metabolic acidosis after radical cystectomy and ileal neobladder.  PLoS ONE. 2016, v.11 no.7. 
  •  Target sequencing and CRISPR/Cas editing reveal simultaneous loss of UTX and UTY in urothelial bladder cancer.  ONCOTARGET. 2016, v.7 no.39, 63252-63260. 
  •  Body image following radical cystectomy and ileal neobladder or conduit in Korean patients.  Korean Journal of Urology. 2014, v.55 no.3, 161-166. 
  •  Comprehensive Analysis of Sexual Function Outcome in Prostate Cancer Patients After Robot-Assisted Radical Prostatectomy.  JOURNAL OF ENDOUROLOGY. 2014, v.28 no.2, 172-177. 
  •  Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction.  BRITISH JOURNAL OF CANCER. 2014, v.110 no.6, 1634-1644.